Litigation partner Michael Lohnes was recently quoted in an article entitled, "The Rising Price of Dealmaking," published in the July 1 issue of Crain's Chicago Business. The article focuses on health care companies and their rush to expand through continued mergers and acquisitions, which has sparked a growing number of shareholder lawsuits. These lawsuits are based on a US Securities & Exchange Commission rule that prohibits any act or omission that results in fraud or deceit related to the sale or purchase of a security. To move forward, Michael says, cases "must establish, among other things, a material misrepresentation or omission and a wrongful state of mind, meaning conscious misconduct or severe recklessness." (Read "The Rising Price of Dealmaking," July 1, 2017)